Hinge Health, Inc.
HNGE
$40.91
-$1.20-2.85%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 130.27% | 77.51% | -2,850.90% | -36.79% | 7,851.91% |
| Total Depreciation and Amortization | -7.27% | 3.87% | 7.95% | -11.13% | -8.12% |
| Total Amortization of Deferred Charges | 12.55% | 15.56% | 14.91% | 1.61% | 18.87% |
| Total Other Non-Cash Items | -87.43% | -71.31% | 27,254.16% | -10.63% | -23.19% |
| Change in Net Operating Assets | -103.88% | 432.62% | 58.23% | -1,977.86% | -107.12% |
| Cash from Operations | -22.46% | 307.41% | 310.66% | -87.15% | 35.01% |
| Capital Expenditure | -684.62% | 73.60% | -286.27% | 67.52% | 50.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.48% | -1,491.77% | 124.41% | -484.38% | -204.05% |
| Cash from Investing | 35.84% | -1,561.25% | 118.85% | -585.00% | -223.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,546.33% | -99.79% | 263,646.39% | -53.37% | 66.40% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -1,575.77% | 257.57% | -1,665.97% |
| Cash from Financing | -15,080.23% | 100.70% | -1,941.08% | 275.76% | -12,189.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -320.70% | 147.11% | -317.10% | -137.40% | 6.42% |